Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Protalix BioTherapeutics Inc. (DE), 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Protalix BioTherapeutics Inc. (DE) June 25, 202692.6%
-
Protalix BioTherapeutics Inc. (DE) June 26, 202592.2%
-
Protalix BioTherapeutics Inc. (DE) June 27, 202483.7%
-
Protalix BioTherapeutics Inc. (DE) June 28, 202393.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 3, 2025 | Protalix BioTherapeutics Inc. (DE) | Grant or award | +7,500 | — | — |
Questions about Pol F. Boudes
What boards is Pol F. Boudes on?
Pol F. Boudes sits on the board of Protalix BioTherapeutics Inc. (DE).
How long has Pol F. Boudes served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.